BENEV, established in California in 2000, is an FDA-registered drug manufacturer, specializing mainly in topical solutions for skin and hair, including its exosome products, as well as innovative medical devices such as PDO threads and radiofrequency microneedling device, in the U.S. and around the world. BENEV is an established player in the medical aesthetic market emphasizing health, longevity, and beauty-related products in the U.S., Asia and other marketing around the world. BENEV has a fully integrated business model, which includes manufacturing, research and development, sales, and marketing.
For more information, susan@benev.com
SOURCE BENEV Company Inc.

BENEV Company

ExoCoBio, established in 2017, is the world's leader in exosome-based regenerative aesthetics and medicine. It is one of top 3 exosome biotech companies and commercialized ASCE+TM and ERCTM, the world's first and best exosome-based aesthetic products, which led to a new exosome skin booster industry since 2019.

http://exocobio.com/

ExoCoBio

ExoCoBio, a global leader in exosome-based regenerative aesthetics, is pleased to announce that they have completed the acquisition of a majority ownership in BENEV, a global medical aesthetic company based in the U.S.

Exocobio, A Leader In Exosome Technology, Completes The Acquisition Of Benev, A Global Medical Aesthetic Brand

Exocobio, A Leader In Exosome Technology, Completes The Acquisition Of Benev, A Global Medical Aesthetic Brand

Company Info